JP2020517597A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020517597A5 JP2020517597A5 JP2019555835A JP2019555835A JP2020517597A5 JP 2020517597 A5 JP2020517597 A5 JP 2020517597A5 JP 2019555835 A JP2019555835 A JP 2019555835A JP 2019555835 A JP2019555835 A JP 2019555835A JP 2020517597 A5 JP2020517597 A5 JP 2020517597A5
- Authority
- JP
- Japan
- Prior art keywords
- benzamide
- methoxyethyl
- phenyl
- methylsulfonamide
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022195986A JP2023071181A (ja) | 2017-04-24 | 2022-12-07 | 軟骨形成を誘導するための方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762489397P | 2017-04-24 | 2017-04-24 | |
| US62/489,397 | 2017-04-24 | ||
| PCT/US2018/028939 WO2018200411A1 (en) | 2017-04-24 | 2018-04-23 | Methods for inducing chondrogenesis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022195986A Division JP2023071181A (ja) | 2017-04-24 | 2022-12-07 | 軟骨形成を誘導するための方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020517597A JP2020517597A (ja) | 2020-06-18 |
| JP2020517597A5 true JP2020517597A5 (https=) | 2021-05-20 |
Family
ID=63919101
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019555835A Pending JP2020517597A (ja) | 2017-04-24 | 2018-04-23 | 軟骨形成を誘導するための方法 |
| JP2022195986A Pending JP2023071181A (ja) | 2017-04-24 | 2022-12-07 | 軟骨形成を誘導するための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022195986A Pending JP2023071181A (ja) | 2017-04-24 | 2022-12-07 | 軟骨形成を誘導するための方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20210361600A1 (https=) |
| EP (1) | EP3615021A4 (https=) |
| JP (2) | JP2020517597A (https=) |
| KR (1) | KR20190137904A (https=) |
| CN (1) | CN110809468A (https=) |
| AU (1) | AU2018257769A1 (https=) |
| CA (1) | CA3060518A1 (https=) |
| MA (1) | MA48479A (https=) |
| RU (1) | RU2019136884A (https=) |
| WO (1) | WO2018200411A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12186307B2 (en) | 2019-02-13 | 2025-01-07 | Yale University | Methods of treating epilepsy |
| FI129515B (en) | 2020-11-06 | 2022-03-31 | Salarusta Oy | FOR USE IN THE PREVENTION AND / OR TREATMENT OF A DISEASE OR CONDITION RELATED TO THE DEGRADATION AND / OR DISTURBANCE OF THE DEGREE OF MONTOOSASE AND / OR INTEGRITY |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9464065B2 (en) * | 2011-03-24 | 2016-10-11 | The Scripps Research Institute | Compounds and methods for inducing chondrogenesis |
| HK1224172A1 (zh) * | 2013-03-15 | 2017-08-18 | 加州生物医学研究所 | 用於诱导软骨形成的化合物和方法 |
| DK3143026T3 (da) * | 2014-05-13 | 2024-09-30 | Novartis Ag | Forbindelser og sammensætninger til induktion af chondrogenese |
-
2018
- 2018-04-23 EP EP18791842.0A patent/EP3615021A4/en not_active Withdrawn
- 2018-04-23 US US16/606,672 patent/US20210361600A1/en not_active Abandoned
- 2018-04-23 KR KR1020197034179A patent/KR20190137904A/ko not_active Ceased
- 2018-04-23 CN CN201880042328.6A patent/CN110809468A/zh active Pending
- 2018-04-23 CA CA3060518A patent/CA3060518A1/en active Pending
- 2018-04-23 MA MA048479A patent/MA48479A/fr unknown
- 2018-04-23 AU AU2018257769A patent/AU2018257769A1/en not_active Abandoned
- 2018-04-23 WO PCT/US2018/028939 patent/WO2018200411A1/en not_active Ceased
- 2018-04-23 RU RU2019136884A patent/RU2019136884A/ru unknown
- 2018-04-23 JP JP2019555835A patent/JP2020517597A/ja active Pending
-
2022
- 2022-12-07 JP JP2022195986A patent/JP2023071181A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20250148T1 (hr) | Specifični triptamini za uporabu u liječenju poremećaja raspoloženja | |
| JP2013543896A5 (https=) | ||
| MX2024001849A (es) | Antagonista del receptor del factor de liberacion de corticotropina 1 (crf1), formulaciones farmaceuticas y formas solidas del mismo para el tratamiento de hiperplasia suprarrenal congenita. | |
| JP2017222722A5 (https=) | ||
| NO20052883L (no) | Nye medikamenter for behandling av kronisk obstruktiv luftveissykdom. | |
| ATE339954T1 (de) | Kombinationen von formoterol und tiotropium-salz | |
| DE60003160D1 (de) | Kombinationen von formoterol und mometasonfuroat | |
| JP2016163571A5 (https=) | ||
| MX2021004110A (es) | Composiciones farmaceuticas que comprenden n-(3,5- dimetoxifenil)-n'-(1-metiletil)-n-[3-(1-metil-1h- pirazol-4-il)quinoxalin-6-il]etano-1,2-diamina. | |
| CN110036005A (zh) | 酰胺衍生物及其在药物中的应用 | |
| DE602006017261D1 (de) | Behandlung von neovaskulären augenerkrankungen, wie z.b. maculadegeneration, angioiden streifen, uveitis und makulaödemen | |
| CY1114803T1 (el) | Παραγωγα πυριμιδινο σουλφοναμιδιου ως ρυθμιστες υποδοχεων χημειοκινης | |
| PH12017500479B1 (en) | Liquid inhalation formulation comprising rpl554 | |
| JP2020532547A5 (https=) | ||
| JP2016515546A5 (https=) | ||
| MY208983A (en) | Pharmaceutical composition for oral administration comprising aminopyrimidine derivative or its salt | |
| JP2016506386A5 (https=) | ||
| JP2019536812A5 (https=) | ||
| JP2020517597A5 (https=) | ||
| ZA202201828B (en) | Therapeutic fusion proteins | |
| JP2010502664A5 (https=) | ||
| JP2020529995A5 (https=) | ||
| MX2020011474A (es) | Nuevo tratamiento de enfermedades pulmonares intersticiales. | |
| HRP20241716T1 (hr) | Postupci liječenja promjena u ponašanju | |
| JP2023071181A5 (https=) |